Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: persons (493), folks (1)

Removing your catheter at home - Trial without catheter (TWOC) after your robotic-assisted radical prostatectomy - patient information

Description: This factsheet explains what a trial without catheter (TWOC) involves after having a robotic-assisted radical prostatectomy.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Removing-your-catheter-at-home-Trial-without-catheter-TWOC-after-your-robotic-assisted-radical-prostatectomy-4007-PIL.pdf

Maternity and Newborn Safety Investigations (MNSI) - patient information

Description: This factsheet explains the Maternity and Newborn Safety Investigations (MNSI) process at University Hospital Southampton NHS Foundation Trust.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Maternity-and-Newborn-Safety-Investigations-MNSI-3163-PIL.pdf

Papers CoG 16.07.2025

Description: Date Time Location Chair Agenda Council of Governors 16/07/2025 14:00 - 15:30 Conference Room, Heartbeat/Microsoft Teams Jen
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-16.07.2025.pdf

Botox treatment for an overactive bladder - patient information

Description: This factsheet contains information about having Botox treatment for an overactive bladder.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Botox-treatment-for-an-overactive-bladder-1335-PIL.pdf

BRC_SDE Joint Funding Call CLEAN

Description: NIHR Southampton BRC and Wessex SDE joint funding call 2025 NIHR Southampton Biomedical Research Centre (BRC) and Wessex Secure Data Environment (
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-SDE-Joint-Funding-Call-CLEAN.pdf

Institutional information_2024-25

Description: Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same
Url: /Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2024-25.pdf

Carboplatin-Etoposide

Description: Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6)-ETOPOSIDE (Intravenous / Oral) • SCLC – Carb
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin-Etoposide-intravenous-and-oral.pdf

Carboplatin (AUC6) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Dacomitinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DACOMITINIB Regimen • NSCLC - Dacomitinib Indication Dacomitinib for untreated EGFR-positive non-small-cell
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Dacomitinib.pdf

Clofarabine

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CLOFARABINE In-Patient Regimen Clofarabine not licensed in adult patients. This may require funding Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Clofarabine.pdf

251 to 260 of 699

Previous … 24 25 26 27 28 … Next